Safety/Tolerability Study of AV-412 in Subjects With Refractory or Relapsed Solid Tumor Malignancies
type: MedicalStudy
description: A Phase 1, Sequential Cohort, Dose Escalation Trial to Determine the Safety, Tolerability, and Maximum Tolerated Dose of Daily Oral Administration of AV-412 in Patients With Refractory or Relapsed Solid Tumor Malignancies
status: TERMINATED
study design: INTERVENTIONAL
phase: PHASE1
start date: 2006-10
end date: 2010-02
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00381654
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: AVEO Pharmaceuticals, Inc.
study subject: Tumor
keywords: PHASE1
keywords: INTERVENTIONAL
keywords: TERMINATED
keywords: Tumor

AI Analytics
type: Organization